Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FARICIMAB-SVOA for Uveitis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where FARICIMAB-SVOA was used for Uveitis.

Most Reported Side Effects for FARICIMAB-SVOA

Side Effect Reports % Deaths Hosp.
Off label use 453 23.7% 27 28
No adverse event 259 13.6% 0 0
Death 158 8.3% 153 1
Visual impairment 146 7.7% 1 15
Eye inflammation 136 7.1% 0 5
Blindness 127 6.7% 0 8
Endophthalmitis 125 6.6% 1 9
Uveitis 102 5.4% 0 12
Vitritis 90 4.7% 0 13
Drug ineffective 82 4.3% 0 3
Vision blurred 80 4.2% 0 10
Iridocyclitis 76 4.0% 0 9
Vitreous floaters 65 3.4% 0 3
Eye pain 61 3.2% 0 10
Retinal haemorrhage 51 2.7% 0 3

Other Indications for FARICIMAB-SVOA

Neovascular age-related macular degeneration (725) Product used for unknown indication (473) Diabetic retinal oedema (256) Age-related macular degeneration (117) Retinal vein occlusion (104) Macular oedema (77) Diabetic retinopathy (71) Macular degeneration (67) Choroidal neovascularisation (65) Dry age-related macular degeneration (19)

Other Drugs Used for Uveitis

ADALIMUMAB (5,600) INFLIXIMAB (633) METHOTREXATE (483) PREDNISONE (341) PREDNISOLONE (262) DEXAMETHASONE (216) MYCOPHENOLATE MOFETIL (200) CORTICOTROPIN (180) TOCILIZUMAB (176) FLUOCINOLONE ACETONIDE (131)

Related Pages

FARICIMAB-SVOA Full Profile All Uveitis Drugs FARICIMAB-SVOA Demographics FARICIMAB-SVOA Timeline